News & Events

Model Informed Drug Development Significantly Expedites 505(b)(2) Program
Rochelle, Virginia (February 25, 2020)
Former Boehringer Ingelheim Regulatory Affairs and Quality Executive Joins NDA Partners as Expert Consultant
Rochelle, Virginia (February 12, 2020)
Dr. Linda McKibben, Former FDA Pediatric Medical Officer, Division of Vaccines and Related Products, Joins NDA Partners
Rochelle, Virginia (January 29, 2020)
NDA Partners. The Democratization of Medical Product Development
Rochelle, Virginia (December 17, 2019)
Internationally Recognized Healthcare Executive, Diane Jorkasky, MD, FACP, Joins NDA Partners
Rochelle, Virginia (December 11, 2019)
Marque D. Todd, MS, DVM, DABT, Joins NDA Partners as Regulatory Toxicology Expert
Rochelle, Virginia (December 4, 2019)
Senior Regulatory Affairs and Program Management Executive, Robert Peterson, RAC, Joins NDA Partners
Rochelle, Virginia (November 13, 2019)
Former Vice President and Global Head of Quantitative Clinical Pharmacology at AstraZeneca Joins NDA Partners
Rochelle, Virginia (November 6, 2019)
Former Executive Director of Preclinical Safety at Novartis, Klaus Peter Hoffmann, MD, PhD, Joins NDA Partners as Expert
Rochelle, Virginia (September 18, 2019)
Former FDA Associate Director for Genomics, Felix Frueh, PhD, Joins NDA Partners as Expert Consultant
Rochelle, Virginia (September 4, 2019)
NDA Partners Named as one of the Top Ten Medical Device Consulting Companies in 2019 by MedTech Outlook
Rochelle, Virginia (August 29, 2019)
The Quality Management System (QMS) Pitfalls of Medical Device Entrepreneurship
Med Tech Outlook (August 13, 2019)
The Key to Successful Software as a Medical Device (SaMD) Implementation
Med Tech Outlook (August 13, 2019)
Five Fundamental Principles for Optimal Medical Product Development
Med Tech Outlook (August 13, 2019)
Senior Regulatory Affairs Executive, Gregory T. Bates, DVM, Joins NDA Partners as Expert Consultant
Rochelle, Virginia (July 31, 2019)
Former OrthoLogic Quality Assurance Director, Donna Hartzfeld, PhD, Joins NDA Partners
Rochelle, Virginia (July 24, 2019)
Head of NDA Partners wins Business Worldwide Magazine's CEO Award for Innovation in Life Sciences Consultancy
London (July 8, 2019)
New consultancy service aids growth of pharma disruptors
London (June 16, 2019)
Andrea Miller, Quality Assurance Expert, Joins NDA Partners as Expert Consultant
Rochelle, Virginia (June 12, 2019)
Report on the current status of the use of real-world data (RWD) and real-world evidence (RWE) in drug development and regulation
British Journal of Clinical Pharmacology (June 7, 2019)
Former FDA Associate Director, Office of Epidemiology & Biostatistics (CDER), William Fairweather, PhD, PSTAT, Joins NDA Partners
Rochelle, Virginia (May 29, 2019)
Leo Kawai, PhD, Distinguished Translational Drug Research and Development Expert, Joins NDA Partners
Rochelle, Virginia (May 22, 2019)
Johannes N. van den Anker, MD, PhD, Prominent Neonatal and Pediatric Clinical Pharmacologist, Joins NDA Partners
Rochelle, Virginia (May 15, 2019)
Former Vice President, Biometrics at GRAIL, Inc., Tara Maddala, PhD, Joins NDA Partners as Expert Consultant
Rochelle, Virginia (April 24, 2019)
Dr. Constance Benson, Internationally Recognized HIV and TB Researcher and Clinician, Joins NDA Partners
Rochelle, Virginia (April 10, 2019)
NDA Partners Awarded the Best Life Sciences Management & Contract Development Organisation 2019 – USA by Global Health & Pharma
Rochelle, Virginia (March 27, 2019)
Mark Gonitzke, RPh, MBA, Former FDA Regulatory Reviewer, Office of Generic Drugs, Joins NDA Partners as Expert Consultant
Rochelle, Virginia (March 20, 2019)
Dr. Francesca Joseph, Former FDA Medical Officer, Office of Orphan Products Development, Joins NDA Partners
Rochelle, Virginia (February 13, 2019)